Prothena Corp Public (PRTA) Prepaid Assets (2012 - 2026)
Prothena Corp Public (PRTA) recorded quarterly Prepaid Assets of $9.7 million in Q1 2026, up 27.11% quarter-over-quarter from $7.7 million in Q4 2025, and down 46.6% on a YoY basis from $18.2 million in Q1 2025.
Prothena Corp Public (PRTA) Prepaid Assets (2012 - 2026) Analysis & Trends
Prothena Corp Public's Prepaid Assets history runs 15 years deep, the most recent figure standing at $9.7 million for Q1 2026.
- In Q1 2026, Prepaid Assets fell 46.6% year-over-year to $9.7 million; the TTM figure through Mar 2026 stood at $9.7 million (down 46.6% YoY), while the FY2025 annual figure was $7.7 million, down 45.37% from the prior year.
- Prepaid Assets was $9.7 million for Q1 2026 at Prothena Corp Public, up from $7.7 million in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $28.9 million in Q3 2022 to a low of $7.7 million in Q4 2025.
- Historically, Prepaid Assets has averaged $14.6 million across 5 years, with a median of $14.0 million in 2024.
- The sharpest annual moves came in 2022 and 2023: Prepaid Assets surged 293.5% in 2022, then tumbled 54.39% in 2023.
- A 5-year view of Prepaid Assets shows it stood at $8.7 million in 2022, then soared by 60.39% to $13.9 million in 2023, then increased by 0.6% to $14.0 million in 2024, then slumped by 45.37% to $7.7 million in 2025, then grew by 27.11% to $9.7 million in 2026.
- The last three Prepaid Assets figures came in at $9.7 million (Q1 2026), $7.7 million (Q4 2025), and $9.1 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Prothena Corp Public | 479.08 Mn | 149.61 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9.74 Mn |
| Dec 31, 2025 | 7.66 Mn |
| Sep 30, 2025 | 9.13 Mn |
| Jun 30, 2025 | 14.04 Mn |
| Mar 31, 2025 | 18.24 Mn |
| Dec 31, 2024 | 14.02 Mn |
| Sep 30, 2024 | 15.72 Mn |
| Jun 30, 2024 | 21.85 Mn |
| Mar 31, 2024 | 18.00 Mn |
| Dec 31, 2023 | 13.94 Mn |
| Sep 30, 2023 | 13.20 Mn |
| Jun 30, 2023 | 16.12 Mn |
| Mar 31, 2023 | 14.16 Mn |
| Dec 31, 2022 | 8.69 Mn |
| Sep 30, 2022 | 28.93 Mn |
| Jun 30, 2022 | 12.50 Mn |
| Mar 31, 2022 | 12.63 Mn |
| Dec 31, 2021 | 5.72 Mn |
| Sep 30, 2021 | 7.35 Mn |
| Jun 30, 2021 | 8.28 Mn |